title: Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
abstract: By using a series of overlapping synthetic peptides covering 98% of the amino acid sequence of the nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus (SARS-CoV), four helper T-cell (Th) epitopes (NP11, residues 11 to 25; NP51, residues 51 to 65; NP61, residues 61 to 75; and NP111, residues 111 to 125) in C57BL mice (H-2(b)), four (NP21, residues 21 to 35; NP91, residues 91 to 105; NP331, residues 331 to 345; and NP351, residues 351 to 365) in C3H mice (H-2(k)), and two (NP81, residues 81 to 95; and NP351, residues 351 to 365) in BALB/c mice (H-2(d)) have been identified. All of these peptides were able to stimulate the proliferation of NP-specific T-cell lines or freshly isolated lymph node cells from mice immunized with recombinant NP. Immunization of mice with synthetic peptides containing appropriate Th epitopes elicited strong cellular immunity in vivo, as evidenced by delayed-type hypersensitivity. Priming with the helper peptides (e.g., NP111 and NP351) significantly accelerated the immune response induced by recombinant NP, as determined by the production of NP-specific antibodies. When fused with a conserved neutralizing epitope (SP1143-1157) from the spike protein of SARS-CoV, NP111 and NP351 assisted in the production of high-titer neutralizing antibodies in vivo. These data provide useful insights regarding immunity against SARS-CoV and have the potential to help guide the design of peptide-based vaccines.
authors: Department of Immunology, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083, China.
authors: Jincun
authors: J
authors: Zhao
authors: Qianrong
authors: Q
authors: Huang
authors: Wei
authors: W
authors: Wang
authors: Yan
authors: Y
authors: Zhang
authors: Ping
authors: P
authors: Lv
authors: Xiao-Ming
authors: XM
authors: Gao
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D000086462:Coronavirus Nucleocapsid Proteins; D018984:Epitopes, T-Lymphocyte / Q000008:administration & dosage / Q000737:chemistry* / Q000302:isolation & purification; D005260:Female; D006801:Humans; D016056:Immunodominant Epitopes / Q000008:administration & dosage / Q000737:chemistry* / Q000302:isolation & purification; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D019590:Nucleocapsid Proteins / Q000008:administration & dosage / Q000737:chemistry* / Q000302:isolation & purification; D045473:Severe acute respiratory syndrome-related coronavirus / Q000737:chemistry / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology* / Q000821:virology*; D014709:Vero Cells
chemical_list: D000086462:Coronavirus Nucleocapsid Proteins; D018984:Epitopes, T-Lymphocyte; D016056:Immunodominant Epitopes; D019590:Nucleocapsid Proteins